Clinical Trial Update: Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating Vimovo (naproxen/esomeprazole) for reducing gastric ulcers in high-risk subjects compared with Arthrotec. The study was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• VIMOVO (naproxen/esomeprazole)

Snippet

Sponsor: POZEN | Conditions: Gastric Ulcer | Phase 3 | Status: TERMINATED | Results posted: 2010-09-22